SEP 07, 2020 1:25 PM PDT

Identifying Robust Tumor Features for Better Radiomics

WRITTEN BY: Jasper Cantrell

With the advancement of technology comes the renovation of classical medical techniques. Diagnostic is one of the areas seeing a significant overhaul, with biological, mechanical, and computational advances making new tests far more effective, at least in theory.

Radiomics has emerged as one of the potential diagnostic technologies to replace biopsies in cancer. It utilizes an MRI, alongside specially designed analytical software, to look at the actual physiological features of tumor. Biopsies take physical sample from a tumor to test, which can give incomplete results as tumors are sometimes “layered” with varied compositions. Radiomics would be a non-invasive method with better results, however, these methods are still new and need to be validated for effectiveness and usability.  

A new study from Maastricht University in the Netherlands sought to identify “robust” features from two commonly used radiomic programs. These features would be strong tumor features that don’t change from tumor to tumor. They had an experienced radiologist, a radiologist in training, and both a medical and Ph.D. student perform the tests. The resulting data would be analyzed for features that were consistently present regardless of program or operator.

The study gathered data from 129 breast cancer patients and used the programs RadiomiX and Pyradiomics to identify the type of breast cancer for each patient. Operator variability was fairly consistent regardless of experience. They highest variability was seen in the “challenging” tumor group, where “easy” tumors were far more uniform.

To identify “robust” features, they looked through and identified features that were consistently in the data. Analysis of each program revealed 41.6% of the features in the RadiomiX data were “robust”, while 32.8% were robust in Pyradiomics. These numbers decreased significantly when looking at “challenging” tumors, inferring a weakness in the tests for more complex tumors.

This study identified a list of robust features, independent of the test operator. These features changed depending on the complexity of the tumor being analyzed. The team hope this list may help develop more automated analyses, which would speed up the process and take out inter-operator variability all together.

The study concludes, “In conclusion, this study shows the intuitive notion that more complex, challenging tumors lead to less robust features” and “Ultimately, this study identified a list of robust radiomics features, which is independent of inter-observer segmentation variability in breast MRI for two commonly used software.”

Sources: Nature Scientific Reports, Alpha Grid

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
AUG 14, 2020
Cancer
Controlling Tumor Blood Flow to Increase Therapy Effectiveness
AUG 14, 2020
Controlling Tumor Blood Flow to Increase Therapy Effectiveness
Nowadays, most cancer drugs target a protein or inhibit a critical cellular process. Modern therapies have varying level ...
AUG 16, 2020
Cancer
Cancer mapping shows health disparities in remote areas
AUG 16, 2020
Cancer mapping shows health disparities in remote areas
Scientists mapping cancer statistics have developed a new mathematical model to track health inequalities relating to th ...
SEP 14, 2020
Cancer
We are too uneducated on the risks of colon cancer
SEP 14, 2020
We are too uneducated on the risks of colon cancer
A study conducted by researchers from Florida Atlantic University's Schmidt College of Medicine suggests that too ma ...
SEP 22, 2020
Cardiology
Investigating the Mechanism Behind 5-Fluorouracil's Cardiotoxicity
SEP 22, 2020
Investigating the Mechanism Behind 5-Fluorouracil's Cardiotoxicity
Cancer therapies have come quite far, with several options available for many cancers. An issue that has plagued many of ...
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
OCT 09, 2020
Cancer
Cloud technology cuts improve efficiency for cancer nurses
OCT 09, 2020
Cloud technology cuts improve efficiency for cancer nurses
In a new study reported in Clinical Cancer Informatics, an American Society of Clinical Oncology journal, medical provid ...
Loading Comments...